7月31日，中信金属今日收盘7.79元，下跌4.77%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到14.38倍，总市值381.71亿元。 从行业市盈率排名来看，公司所处的贸易行业行业市盈率平均46.29倍，行业中值37.73倍，中信金属排 名第16位。 股东方面，截至2025年6月9日，中信金属股东户数80949户，较上次增加1028户，户均持股市值35.28万 元，户均持股数量2.76万股。 中信金属股份有限公司的主营业务是金属及矿产品的贸易业务。公司的主要产品是铌、铜、铝、镍等有 色金属产品以及铁矿石、钢材、铬矿、锰矿。公司作为全球最大的铌产品供应商CBMM在中国的独家 分销商，在国内铌产品市场约占80%的市场份额。目前公司处于中国铜精矿贸易企业的前列，未来公司 凭借LasBambas和艾芬豪的股权投资，以及相应的铜精offtake为基础，不断提高铜精矿的市场份额以及 国际影响力。 最新一期业绩显示，2025年一季报，公司实现营业收入282.49亿元，同比5.28%；净利润5.71亿元，同 比268.89%，销售毛利率2.01%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5 ...

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of State Grid Yingda, which operates in the diversified financial sector with a current PE ratio of 17.26, significantly lower than the industry average of 70.42 [1][2] - As of May 9, 2025, State Grid Yingda has 62,663 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company reported a revenue of 2.218 billion yuan for Q1 2025, representing a year-on-year increase of 8.65%, and a net profit of 604 million yuan, reflecting a year-on-year growth of 45.22% [1] Group 2 - The average PE ratio for the diversified financial industry is 70.42, with a median of 30.39, positioning State Grid Yingda in the 8th place among its peers [2] - The total market capitalization of State Grid Yingda is 30.422 billion yuan, indicating its substantial presence in the market [2] - The company's sales gross margin stands at 13.45%, which is a critical metric for assessing its profitability [1]

Group 1 - The core viewpoint of the articles highlights that the company, 大东方, has a current stock price of 4.96 yuan, with a rolling PE ratio of 71.76 times, which is significantly higher than the industry average of 48.19 times and the median of 59.42 times [1][2] - As of March 31, 2025, the number of shareholders for 大东方 is 82,560, a decrease of 10,189 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] - The main business operations of 大东方 include department store retail, the operation of the Sanfengqiao brand, and healthcare services, with notable achievements such as being recognized among the "Top 500 Private Enterprises in China" and "Top 100 Private Service Enterprises in China" [1] Group 2 - The latest financial performance report for the first quarter of 2025 shows that 大东方 achieved a revenue of 921 million yuan, representing a year-on-year decrease of 8.55%, while the net profit was 39.93 million yuan, reflecting a significant year-on-year decline of 78.14%, with a sales gross margin of 19.46% [1] - In the industry context, 大东方 ranks 35th in terms of PE ratio among its peers, indicating a relatively high valuation compared to the average and median ratios in the healthcare service sector [2] - The industry average PE ratio is 48.19 times, while the median is 59.42 times, suggesting that 大东方's valuation is above both benchmarks [2]

Company Overview - Shanmei International closed at 9.59 yuan, down 4.20%, with a rolling PE ratio of 9.80 times and a total market value of 19.012 billion yuan [1] - The company's main business includes coal production, sales, and logistics, with primary products being self-produced coal and washed coal [1] Financial Performance - For Q1 2025, the company reported operating revenue of 4.502 billion yuan, a year-on-year decrease of 29.17%, and a net profit of 255 million yuan, down 56.29% year-on-year, with a sales gross margin of 33.13% [1] Industry Comparison - The average PE ratio for the coal industry is 13.00 times, with a median of 13.08 times, placing Shanmei International at 18th in the industry ranking [1] - The company is held by 16 institutions, including 16 funds, with a total holding of 33.2253 million shares valued at 290 million yuan [1] Valuation Metrics - Shanmei International's PE (TTM) is 9.80, while the industry average is 13.00, indicating a lower valuation compared to peers [2] - The company's market value stands at 19.012 billion yuan, compared to the industry median market value of 119.92 billion yuan [2]

Company Overview - Aidi Te (Qinhuangdao) Technology Co., Ltd. specializes in the research, production, and sales of dental restoration materials and digital dental equipment [1] - The main products include dental restoration materials and digital dental devices [1] Financial Performance - For Q1 2025, the company reported revenue of 205 million yuan, representing a year-on-year increase of 18.07% [1] - The net profit for the same period was 31.27 million yuan, showing a year-on-year growth of 34.21% [1] - The gross profit margin stood at 51.00% [1] Market Position - As of July 31, Aidi Te's closing stock price was 49.66 yuan, down 2.63%, with a rolling price-to-earnings (PE) ratio of 33.40 [1] - The company's total market capitalization is 5.292 billion yuan [1] - In comparison to the medical device industry, which has an average PE of 54.89 and a median of 37.06, Aidi Te ranks 67th [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders for Aidi Te was 8,036, a decrease of 548 from the previous count [1] - The average market value of shares held per shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]

Core Insights - The company Xin Heng Hui closed at 67.02 yuan on July 31, with a 3.11% increase, resulting in a rolling PE ratio of 86.88 times and a total market capitalization of 16.055 billion yuan [1][2] - The semiconductor industry has an average PE ratio of 104.83 times and a median of 69.03 times, placing Xin Heng Hui at the 123rd position within the industry [1][2] - As of the first quarter of 2025, 188 institutions hold shares in Xin Heng Hui, with a total holding of 99,200 shares valued at 0.06 billion yuan [1] Company Overview - Xin Heng Hui Electronic Co., Ltd. specializes in the research, production, sales, and packaging testing services of chip packaging materials [1] - The main products include smart card business, etched lead frames, and IoT eSIM chip testing [1] - The company has a skilled R&D and production team and has established national standards for integrated circuit (IC) card packaging frames [1] Recent Performance - In the first quarter of 2025, the company reported an operating income of 241 million yuan, a year-on-year increase of 24.71% [2] - The net profit was 51.3165 million yuan, reflecting a year-on-year decrease of 2.26% [2] - The sales gross margin stood at 32.53% [2] Industry Comparison - Xin Heng Hui's PE ratio of 86.88 times is compared to the industry average of 104.83 times and the median of 69.03 times [2] - Other companies in the semiconductor industry have varying PE ratios, with the lowest being 26.56 times for Yang Jie Technology and the highest being 39.89 times for Northern Huachuang [2]

Core Viewpoint - In recent trading, Yingke Medical's stock closed at 34.35 yuan, marking a 1.15% increase, with a rolling PE ratio of 14.23, the lowest in 791 days, and a total market capitalization of 22.488 billion yuan [1] Company Summary - Yingke Medical Technology Co., Ltd. specializes in the research, production, and sales of high-performance personal protective products, including disposable nitrile gloves, PVC gloves, PE gloves, isolation gowns, masks, electric wheelchairs, manual wheelchairs, mobility scooters, walkers, electric sofas, bedside tables, ice/hot packs, hand sanitizers, heating pads, cooling mats, ECG electrodes, and electrode labels [1] - For Q1 2025, the company reported revenue of 2.494 billion yuan, a year-on-year increase of 13.20%, and a net profit of 353 million yuan, reflecting a year-on-year growth of 48.08%, with a gross profit margin of 24.16% [1] Industry Summary - The average PE ratio for the medical device industry is 54.89, with a median of 37.06, positioning Yingke Medical at 32nd place within the industry [1] - The static PE ratio for Yingke Medical is 15.35, and the price-to-book ratio is 1.27 [2] - Other companies in the industry have varying PE ratios, with the highest being 19.94 for Antu Bio and the lowest at 10.93 for Jiuan Medical [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Baoli International, indicating a significant decline in revenue and profit, alongside a high PE ratio compared to industry averages [1][2] Group 2 - Baoli International's stock closed at 4.34 yuan, down 5.03%, with a rolling PE ratio of 189.31 times, and a total market capitalization of 4 billion yuan [1] - The average PE ratio for the chemical products industry is 48.86 times, with a median of 43.38 times, placing Baoli International at the 156th position in the industry ranking [1][2] - On July 31, Baoli International experienced a net outflow of 20.12 million yuan in principal funds, with a total outflow of 29.40 million yuan over the past five days [1] - The main business of Baoli International includes the production and sales of various asphalt products, as well as helicopter and aviation material sales, and investment in BT projects [1] - The latest quarterly report for Q1 2025 shows Baoli International achieved operating revenue of 230 million yuan, a year-on-year decrease of 42.82%, and a net profit of 3.239 million yuan, down 26.61%, with a sales gross margin of 1.83% [1]

Company Overview - Huayang International closed at 13.64 yuan on July 31, down 3.67%, with a rolling PE ratio of 21.45 times and a total market value of 2.674 billion yuan [1] - The company operates in the engineering consulting services industry, which has an average PE ratio of 62.63 times and a median of 40.81 times, placing Huayang International at the 26th position in the industry ranking [1] - The main business activities include architectural design and consulting, building technology innovation, and extending the industrial chain [1] Financial Performance - For Q1 2025, Huayang International reported revenue of 264 million yuan, a year-on-year increase of 15.36%, while net profit was 2.4757 million yuan, reflecting a year-on-year decrease of 20.22% [1] - The sales gross margin stood at 19.48% [1] Capital Flow - On July 31, the net outflow of main funds for Huayang International was 16.4631 million yuan, with a total outflow of 12.6546 million yuan over the past five days [1]

Company Overview - Weisi Medical's closing price on July 30 was 46.57 yuan, with an increase of 1.70%, resulting in a rolling PE ratio of 39.32 times and a total market value of 4.46 billion yuan [1] - The company operates in the medical device sector, focusing on the research, production, and sales of medical devices, including magnetic stimulation, electrical stimulation, electrophysiology, consumables, and laser radiofrequency products [1] Financial Performance - For the first quarter of 2025, Weisi Medical reported revenue of 95.91 million yuan, representing a year-on-year increase of 9.40% [1] - The net profit for the same period was 33.22 million yuan, showing a significant year-on-year growth of 52.71% [1] - The sales gross margin stood at 66.65% [1] Industry Comparison - The average PE ratio for the medical device industry is 55.15 times, with a median of 37.48 times, positioning Weisi Medical at the 78th rank within the industry [1] - The company has one institutional holder, which is a fund, holding a total of 90,000 shares valued at 0.04 million yuan [1] - The industry average market value is 11.57 billion yuan, indicating that Weisi Medical's market value is significantly lower than the industry average [2]